25 Einträge gefunden

1. Update Mammakarzinom 2021 Teil 5 – fortgeschrittenes Mammakarzinom, Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer

   1. Lüftner, Diana
   2. Schütz, Florian
   3. Stickeler, Elmar
   4. Fasching, Peter A
   5. Janni, Wolfgang
   6. Kolberg-Liedtke, Cornelia
   7. Kolberg, Hans-Christian

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Advanced Breast Cancer:AGO Recommendations 2022 - Focus on ABC6 Consensus

   1. Untch, Michael
   2. Fasching, Peter A
   3. Haidinger, Renate
   4. Harbeck, Nadia
   5. Jackisch, Christian
   6. Lüftner, Diana
   7. Müller, Volkmar

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

   1. Thill, Marc
   2. Lüftner, Diana
   3. Kolberg-Liedtke, Cornelia
   4. Albert, Ute-Susann
   5. Banys-Paluchowski, Maggie
   6. Bauerfeind, Ingo
   7. Blohmer, Jens-Uwe

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference

   1. Kolberg-Liedtke, Cornelia
   2. Lüftner, Diana
   3. Brucker, Sara Y
   4. Budach, Wilfried
   5. Denkert, Carsten
   6. Fasching, Peter A
   7. Haidinger, Renate

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
7. ABC6 Consensus: Assessment by a Group of German Experts

   1. Lüftner, Diana
   2. Fasching, Peter A
   3. Haidinger, Renate
   4. Harbeck, Nadia
   5. Jackisch, Christian
   6. Müller, Volkmar
   7. Schumacher-Wulf, Eva

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
8. Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien, Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer

   1. Welslau, Manfred
   2. Müller, Volkmar
   3. Lüftner, Diana
   4. Schütz, Florian
   5. Stickeler, Elmar
   6. Fasching, Peter A
   7. Janni, Wolfgang

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
9. Update Mammakarzinom 2022 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien, Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer

   1. Müller, Volkmar
   2. Welslau, Manfred
   3. Lüftner, Diana
   4. Schütz, Florian
   5. Stickeler, Elmar
   6. Fasching, Peter A
   7. Janni, Wolfgang

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
10. Update Breast Cancer 2021 Part 4 - Prevention and Early Stages

    1. Thomssen, Christoph
    2. Fehm, Tanja N
    3. Stickeler, Elmar
    4. Fasching, Peter A
    5. Janni, Wolfgang
    6. Kolberg-Liedtke, Cornelia
    7. Kolberg, Hans-Christian

    2022 - Forschungsinformationssystem des UKE - frei zugänglich
11. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
12. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

    1. Lüftner, Diana
    2. Hartkopf, Andreas D
    3. Lux, Michael P
    4. Overkamp, Friedrich
    5. Tesch, Hans
    6. Titzmann, Adriana
    7. Pöschke, Patrik

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
13. Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel

    1. Fehm, Tanja N
    2. Stickeler, Elmar
    3. Fasching, Peter A
    4. Janni, Wolfgang
    5. Kolberg-Liedtke, Cornelia
    6. Kolberg, Hans-Christian
    7. Lüftner, Diana

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
14. Clinical endpoints in real-world registry studies:PRAEGNANT network for women with advanced breast cancer, Klinische Endpunkte in Real-World-Register-Studien: PRAEGNANT-Netzwerk für Patientinnen mit fortgeschrittenem Mammakarzinom

    1. Hartkopf, Andreas D.
    2. Emons, Julius
    3. Lux, Michael P.
    4. Taran, Florin Andrei
    5. Overkamp, Friedrich
    6. Tesch, Hans
    7. Titzmann, Adriana

    2020 - Forschungsinformationssystem des UKE
15. ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Lüftner, Diana
    4. Haidinger, Renate
    5. Fasching, Peter A
    6. Augustin, Doris
    7. Briest, Susanne

    2020 - Forschungsinformationssystem des UKE
16. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

    1. Thomssen, Christoph
    2. Lüftner, Diana
    3. Untch, Michael
    4. Haidinger, Renate
    5. Würstlein, Rachel
    6. Harbeck, Nadia
    7. Augustin, Doris

    2020 - Forschungsinformationssystem des UKE
17. Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer:New Treatments and Implementation of Therapies with Companion Diagnostics

    1. Lüftner, Diana
    2. Schneeweiss, Andreas
    3. Hartkopf, Andreas D
    4. Müller, Volkmar
    5. Wöckel, Achim
    6. Janni, Wolfgang
    7. Ettl, Johannes

    2020 - Forschungsinformationssystem des UKE
18. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

    1. Michel, Laura L
    2. Hartkopf, Andreas D
    3. Fasching, Peter A
    4. Kolberg, Hans-Christian
    5. Hadji, Peyman
    6. Tesch, Hans
    7. Häberle, Lothar

    2020 - Forschungsinformationssystem des UKE
19. Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

    1. Rassaf, Tienush
    2. Totzeck, Matthias
    3. Backs, Johannes
    4. Bokemeyer, Carsten
    5. Hallek, Michael
    6. Hilfiker-Kleiner, Denise
    7. Hochhaus, Andreas

    2020 - Forschungsinformationssystem des UKE
20. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2020 - Forschungsinformationssystem des UKE